David Santos was diagnosed with T-cell acute lymphoblastic leukemia in June 2024, according to a Facebook post. Eight months ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

The foundation hopes to put the funds toward two clinical programs in blood cancers and one preclinical project in solid tumors.

The trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.

It’s Friday, the day we take a few moments to highlight the good news in Lancaster County and the surrounding region. Some of ...

The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital have announced their newest class of ...

Sales of the firm's cell therapy franchise grew modestly in the fourth quarter amid competing product launches and overall slow uptake within the class.

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

Seven-year-old WA boy Ace was diagnosed with Acute Lymphoblastic Leukemia when he was just five years old. Acute ...

Barrett told his grandma Honey, also known as Jill Lee, about the idea.